We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Hester is geared up for commercial production and marketing of its thermo-tolerant PPR vaccine from December 2020 which will be available in packs of 25, 50 and 100 doses.